T. Michigami

K. Ozono, T. Kubota, T. Michigami, 2010, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions

Y. Toyama, M. Kuro-o, K. Miyamoto, 2017, Scientific Reports.

Current understanding on the molecular basis of chondrogenesis.

T. Michigami, 2014, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Current Understanding on the Molecular Basis of Chondrogenesis

T. Michigami, 2014, Clinical Pediatric Endocrinology.

Regulatory mechanisms for the development of growth plate cartilage

T. Michigami, 2013, Cellular and Molecular Life Sciences.

Novel mutations in the a3 subunit of vacuolar H(+)-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis.

K. Ozono, T. Michigami, M. Nakayama, 2002, Bone.

Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta

H. Yoshikawa, K. Ozono, K. Ebina, 2019, Osteoporosis International.

Wnt signaling in bone metabolism

K. Ozono, T. Kubota, T. Michigami, 2009, Journal of Bone and Mineral Metabolism.

C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Paul J. Williams, T. Yoneda, G. Mundy, 2003, Cancer research.

a Newly Developed Model of Human Neuroblastoma Key Molecule of Osteoclast Formation for Bone Metastasis in B Ligand ( RANKL ) Is a κ Receptor Activator of Nuclear Factor Updated

K. Ozono, T. Michigami, M. Ihara-Watanabe, 2001 .

Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.

K. Ozono, T. Michigami, M. Ihara-Watanabe, 2001, Cancer research.

Oncogenic nucleoporin CAN/Nup214 interacts with vitamin D receptor and modulates its function

M. Makishima, K. Ozono, T. Okada, 2009, Journal of cellular biochemistry.

A case of a preschool child with a successful kidney transplant following the long-term administration of antibiotics to treat peritoneal dialysis-related ESI/peritonitis by Mycobacterium abscessus

T. Michigami, K. Yazawa, I. Yanagihara, 2022, CEN Case Reports.

Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

O. Mäkitie, E. Hyppönen, G. Goldberg, 2016, Hormone Research in Paediatrics.

Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

O. Mäkitie, E. Hyppönen, G. Goldberg, 2016, Hormone Research in Paediatrics.

Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

Paul J. Williams, T. Yoneda, T. Michigami, 1999, Cancer treatment reviews.

The Effect of the Bisphosphonate Ibandronate on Breast Cancer Metastasis to Visceral Organs

Paul J. Williams, T. Yoneda, G. Mundy, 2002, Breast Cancer Research and Treatment.

Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood.

Y. Nabeshima, K. Ozono, A. Imura, 2011, The Journal of clinical endocrinology and metabolism.

Importin 4 Is Responsible for Ligand-independent Nuclear Translocation of Vitamin D Receptor*

K. Ozono, Y. Yoneda, J. Pike, 2005, Journal of Biological Chemistry.

Advances in understanding of phosphate homeostasis and related disorders.

T. Michigami, 2022, Endocrine journal.

Pathogenesis of FGF23-Related Hypophosphatemic Diseases Including X-linked Hypophosphatemia

T. Michigami, T. Nakanishi, 2022, Endocrines.

Roles of osteocytes in phosphate metabolism

T. Michigami, 2022, Frontiers in Endocrinology.

K. Ozono, Kanako Tachikawa, T. Michigami, 2022, Bone.

Clonal Osteoblastic cell lines with CRISPR/Cas9-mediated ablation of Pit1 or Pit2 show enhanced mineralization despite reduced Osteogenic gene expression.

K. Ozono, Kanako Tachikawa, T. Michigami, 2021, Bone.

Roles of Phosphate in Skeleton

K. Ozono, T. Michigami, 2019, Front. Endocrinol..

Skeletal mineralization: mechanisms and diseases

T. Michigami, 2019, Annals of pediatric endocrinology & metabolism.

Extracellular Phosphate Induces the Expression of Dentin Matrix Protein 1 Through the FGF Receptor in Osteoblasts

M. Kogo, K. Ozono, Kanako Tachikawa, 2017, Journal of cellular biochemistry.

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

I. Endo, Hiroyuki Tanaka, Toshio Matsumoto, 2008, Bone.

Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.

M. Kogo, K. Ozono, T. Okada, 2010, Bone.

Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolar proton pump.

M. Okada, N. Kurihara, K. Ozono, 1993, The Journal of clinical investigation.

CYP7A1 expression in hepatocytes is retained with upregulated fibroblast growth factor 19 in pediatric biliary atresia

K. Ozono, H. Kondou, T. Michigami, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide

Paul J. Williams, T. Yoneda, M. Nomizu, 1998, Clinical & Experimental Metastasis.

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels

K. Ozono, T. Michigami, M. Kawai, 2020, Scientific Reports.

Elevated Fibroblast Growth Factor 23 Exerts Its Effects on Placenta and Regulates Vitamin D Metabolism in Pregnancy of Hyp Mice

K. Ozono, Hironori Yamamoto, Kanako Tachikawa, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells

K. Ozono, T. Okada, H. Kondou, 2010, Journal of cellular biochemistry.

Role of megalin and the soluble form of its ligand RAP in Cd-metallothionein endocytosis and Cd-metallothionein-induced nephrotoxicity in vivo.

T. Kimura, N. Itoh, T. Nakanishi, 2012, Toxicology letters.

Incidence rate and characteristics of symptomatic vitamin D deficiency in children: a nationwide survey in Japan.

H. Tsukahara, K. Ihara, K. Ozono, 2018, Endocrine journal.

Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.

K. Ozono, T. Michigami, H. Suzuki, 2001, The Journal of endocrinology.

Inorganic Phosphate Activates the AKT/mTORC1 Pathway and Shortens the Life Span of an α‑Klotho-Deficient Model.

K. Ozono, T. Michigami, M. Kawai, 2016, Journal of the American Society of Nephrology : JASN.

A study of the association between serum bone-specific alkaline phosphatase and serum phosphorus concentration or dietary phosphorus intake.

T. Michigami, T. Hosoi, M. Goseki‐Sone, 2012, Journal of nutritional science and vitaminology.

Cellular ATP Synthesis Mediated by Type III Sodium-dependent Phosphate Transporter Pit-1 Is Critical to Chondrogenesis*

T. Yoneda, H. Yoshikawa, A. Amano, 2010, The Journal of Biological Chemistry.

Severe arterial hypertension: a possible complication of McCune-Albright syndrome

S. Ida, K. Ozono, Y. Imanishi, 2009, European Journal of Pediatrics.

Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.

K. Ozono, T. Kishimoto, S. Kasayama, 1996, The Journal of clinical investigation.

Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.

I. Endo, Toshio Matsumoto, K. Ozono, 2015, Endocrine journal.

Clinical Practice Guidelines for Hypophosphatasia*

K. Ozono, T. Kubota, T. Michigami, 2020, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

FGF23 Suppresses Chondrocyte Proliferation in the Presence of Soluble α-Klotho both in Vitro and in Vivo*

K. Ozono, T. Michigami, M. Kawai, 2012, The Journal of Biological Chemistry.

Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society

Toshio Matsumoto, K. Ozono, Y. Takeuchi, 2015, Journal of Bone and Mineral Metabolism.

Osteocytes and the pathogenesis of hypophosphatemic rickets

T. Michigami, M. Yamazaki, 2022, Frontiers in Endocrinology.

Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease

K. Ozono, T. Kubota, T. Michigami, 2017, CEN Case Reports.

[X-linked hypophosphatemic rickets].

T. Michigami, 2007, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Molecular Bases of Diseases Characterized by Hypophosphatemia and Phosphaturia: New Understanding

K. Ozono, T. Michigami, N. Namba, 2006, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

The role of IGF-I in phosphate therapy for the short stature of patients with hypophosphatemic vitamin D-resistant rickets

K. Ozono, T. Michigami, S. Okada, 2005, Journal of Bone and Mineral Metabolism.

Alkaline phosphatase in pediatric patients with genu varum caused by vitamin D-deficient rickets.

K. Ozono, T. Kubota, T. Michigami, 2021, Endocrine journal.

Sp1 Family of Transcription Factors Regulates the Human α2 (XI) Collagen Gene (COL11A2) in Saos‐2 Osteoblastic Cells

D. Eyre, T. Fujita, T. Komori, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Benign prenatal hypophosphatasia: a treatable disease not to be missed

Kanako Tachikawa, T. Michigami, N. Ishiguro, 2014, Pediatric Radiology.

CHAPTER 52 – Vitamin D and Reproductive Organs

K. Ozono, T. Michigami, S. Nakajima, 2005 .

Pathogenesis and diagnostic criteria for rickets and osteomalacia - proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society.

Toshio Matsumoto, K. Ozono, Y. Takeuchi, 2015, Endocrine journal.

Hereditary hypophosphatemic rickets with hypercalciuria: a study for the phosphate transporter gene type IIc and osteoblastic function

K. Ozono, K. Miyamoto, T. Michigami, 2007, Journal of Bone and Mineral Metabolism.

A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.

K. Ozono, T. Michigami, D. Dickey, 2013, Bone.

An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene

H. Yoshikawa, K. Ozono, T. Kubota, 2012, PloS one.

CREB activation in hypertrophic chondrocytes is involved in the skeletal overgrowth in epiphyseal chondrodysplasia Miura type caused by activating mutations of natriuretic peptide receptor B

K. Ozono, T. Kubota, Kanako Tachikawa, 2018, Human molecular genetics.

Current concepts in perinatal mineral metabolism

K. Ozono, T. Michigami, Y. Ohata, 2016, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

FGF 23 Suppresses Chondrocyte Proliferation in the Presence of Soluble-Klotho both in Vitro and in Vivo *

K. Ozono, T. Michigami, M. Kawai, 2013 .

A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia

K. Ozono, T. Michigami, A. Miyauchi, 2001, Journal of Human Genetics.

G-protein Stimulatory α Subunit Is Involved in Osteogenic Activity in Osteoblastic Cell Line SaOS-2 Cells

K. Ozono, Akira Suzuki, T. Michigami, 2006, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

osteoclast-stimulating activity 1-integrin enhances production of β 4 α VCAM-1 and cell contact between marrow stromal cells and myeloma cells via - Cell

Paul J. Williams, T. Yoneda, T. Michigami, 2013 .

Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice

Kimimitsu Oda, N. Amizuka, Minqi Li, 2016, Histochemistry and Cell Biology.

Regulatory mechanisms for the development of growth plate cartilage

T. Michigami, 2013, Cellular and Molecular Life Sciences.

Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporter.

K. Ozono, H. Kondou, T. Michigami, 2005, Journal of the American Society of Nephrology : JASN.

Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme.

P. Schneider, K. Ozono, E. Schönau, 2000, The Journal of clinical endocrinology and metabolism.

Sodium‐coupled neutral amino acid transporter 4 functions as a regulator of protein synthesis during liver development

K. Ozono, H. Kondou, Kanako Tachikawa, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease

K. Ozono, Y. Hasuike, T. Michigami, 2022, Clinical and Experimental Nephrology.

Genomic Organization of the Human Chondromodulin‐1 Gene Containing a Promoter Region That Confers the Expression of Reporter Gene in Chondrogenic ATDC5 Cells

H. Kurahashi, K. Ozono, T. Michigami, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Risk factors associated with a decreased estimated glomerular filtration rate based on cystatin C levels in school‐age children with extremely low birthweight

T. Michigami, H. Kitajima, K. Satomura, 2017, Nephrology.

Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats.

N. Fujii, H. Kimura-Suda, H. Rakugi, 2013, American journal of physiology. Renal physiology.

Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome.

F. Glorieux, K. Ozono, Y. Imanishi, 2014, Bone.

Clinical Practice Guidelines for Achondroplasia*

K. Ozono, T. Kubota, T. Michigami, 2020, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Bisphosphonate Use and Fractures in Adults with Hypophosphatasia

T. Cundy, T. Michigami, M. Dray, 2019, JBMR plus.

Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment

T. Cundy, J. Collins, Kanako Tachikawa, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Severe hypercalcaemia and respiratory insufficiency associated with infantile hypophosphatasia caused by two novel mutations of the tissue-nonspecific alkaline phosphatase gene

K. Ozono, H. Ohashi, T. Michigami, 2000, European Journal of Pediatrics.

Clinical Characteristics of Perinatal Lethal Hypophosphatasia: A Report of 6 Cases

K. Ozono, S. Okada, Masao Kobayashi, 2010, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo.

Y. Etani, K. Ozono, H. Kondou, 2003, Journal of hepatology.

Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein.

K. Ozono, T. Michigami, M. Nakayama, 1996, The Journal of clinical endocrinology and metabolism.

Lack of puberty despite elevated estradiol in a 46,XY phenotypic female with Frasier syndrome.

K. Ozono, Kanako Tachikawa, T. Michigami, 2006, Endocrine journal.

Novel mutation in the ALPL gene with a dominant negative effect in a Japanese family

Y. Kitagawa, Kanako Tachikawa, T. Michigami, 2021, Journal of Bone and Mineral Metabolism.

Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras.

K. Ozono, T. Michigami, S. Mushiake, 1998, The Journal of clinical endocrinology and metabolism.

Hypophosphatasia in Japan: ALPL Mutation Analysis in 98 Unrelated Patients

K. Ozono, T. Kubota, Kanako Tachikawa, 2019, Calcified Tissue International.

Discordant fetal phenotype of hypophosphatasia in two siblings

G. Nishimura, Kanako Tachikawa, T. Michigami, 2018, American journal of medical genetics. Part A.

Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia

T. Uchihashi, K. Ozono, Akira Suzuki, 2005, European Journal of Pediatrics.

Czech dysplasia occurring in a Japanese family

G. Nishimura, Kanako Tachikawa, T. Michigami, 2009, American journal of medical genetics. Part A.

Paracrine and endocrine functions of osteocytes

T. Michigami, 2022, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Phosphate as a Signaling Molecule and Its Sensing Mechanism.

K. Ozono, T. Michigami, M. Kawai, 2018, Physiological reviews.

Clinical and genetical approach to skeletal dysplasia

K. Ozono, T. Michigami, N. Namba, 2006 .

Overgrowth syndrome associated with a gain‐of‐function mutation of the natriuretic peptide receptor 2 (NPR2) gene

T. Cho, K. Ozono, T. Michigami, 2014, American journal of medical genetics. Part A.

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene

K. Ozono, T. Kubota, T. Michigami, 2013, International Journal of Pediatric Endocrinology.

Pediatric aspects of skeletal dysplasia.

K. Ozono, T. Kubota, T. Michigami, 2012, Pediatric Endocrinology Reviews: diabetes, nutrition, metabolism.

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma

Paul J. Williams, T. Yoneda, T. Michigami, 2000, Cancer.

Cell–cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity

Paul J. Williams, T. Yoneda, G. Mundy, 2000 .

Involvement of nuclear factor I transcription/replication factor in the early stage of chondrocytic differentiation.

M. Kogo, T. Uchihashi, K. Ozono, 2007, Bone.

Pseudoautosomal gene SHOX exhibits sex-biased random monoallelic expression and contributes to sex difference in height

K. Okamura, T. Ogata, A. Umezawa, 2021, bioRxiv.

Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth

K. Ozono, T. Michigami, H. Kitajima, 2016, European Journal of Pediatrics.

Causes and differential diagnosis of hypocalcemia--recommendation proposed by expert panel supported by ministry of health, labour and welfare, Japan.

I. Endo, Hiroyuki Tanaka, Toshio Matsumoto, 2008, Endocrine journal.

Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.

Wei Wang, Yasuji Kitabatake, D. Okuzaki, 2016, Bone.

A fatal case of infantile malignant osteopetrosis complicated by pulmonary arterial hypertension after hematopoietic stem cell transplantation.

K. Ozono, C. Ohe, K. Kaneko, 2014, The Tohoku journal of experimental medicine.

A case of autosomal dominant osteopetrosis type II with a novel TCIRG1 gene mutation

Kanako Tachikawa, T. Michigami, Y. Seino, 2013, Journal of pediatric endocrinology & metabolism : JPEM.

Cleidocranial dysplasia with growth hormone deficiency: a case report

S. Matsuo, T. Michigami, J. Mori, 2020, BMC Pediatrics.

A case of a preschool child with a successful kidney transplant following the long-term administration of antibiotics to treat peritoneal dialysis-related ESI/peritonitis by Mycobacterium abscessus

T. Michigami, K. Yazawa, I. Yanagihara, 2022, CEN Case Reports.

Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.

Katsuhiro Kobayashi, T. Akiyama, K. Ozono, 2018, Molecular genetics and metabolism.

Examination of megalin in renal tubular epithelium from patients with Dent disease

K. Ozono, T. Michigami, S. Nakajima, 2004, Pediatric Nephrology.

Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study

H. Cheong, K. Ozono, S. Fukumoto, 2020, BMJ Open.

Identification of novel missense mutations (Phe310Leu and Gly439Arg) in a neonatal case of hypophosphatasia.

K. Ozono, T. Michigami, M. Nakayama, 1996, The Journal of clinical endocrinology and metabolism.

Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin–angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight

S. Kagami, M. Urushihara, T. Michigami, 2020, Pediatric Nephrology.

[Rickets/Osteomalacia. Consensus on Vitamin D Deficiency and Insufficiency in Children.]

T. Michigami, 2018, Clinical calcium.

Hypophosphatasia now draws more attention of both clinicians and researchers: A Commentary on prevelance of c. 1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasias in Japanese and effects of the mutation on heterozygous carriers

K. Ozono, T. Michigami, 2011, Journal of Human Genetics.

Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial

T. Ogata, K. Ozono, S. Okada, 2017, Clinical endocrinology.

Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types

T. Taketani, K. Ozono, T. Kubota, 2019, PloS one.

Oral findings in patient with lethal hypophosphatasia treated with enzyme replacement therapy

T. Michigami, K. Nakano, Kazuma Kokomoto, 2017 .

Findings of amplitude-integrated electroencephalogram recordings and serum vitamin B6 metabolites in perinatal lethal hypophosphatasia during enzyme replacement therapy

T. Akiyama, M. Hayakawa, Yuichiro Sugiyama, 2019, Brain and Development.

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature

T. Akiyama, T. Michigami, Y. Seino, 2018, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Analysis of the rat interpeduncular subnuclei by immunocytochemical double‐staining for enkephalin and substance P, with some reference to the coexistence of both peptides

T. Michigami, K. Shinoda, Y. Shiotani, 1988, The Journal of comparative neurology.

Identification of Amino Acid Sequence in the Hinge Region of Human Vitamin D Receptor That Transfers a Cytosolic Protein to the Nucleus*

K. Ozono, T. Michigami, Chika Shimizu, 1999, The Journal of Biological Chemistry.

Lrp6 Hypomorphic Mutation Affects Bone Mass Through Bone Resorption in Mice and Impairs Interaction With Mesd

K. Ozono, Akira Suzuki, T. Kubota, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.

K. Ozono, H. Mabe, Kenichi Yamamoto, 2021, Bone.

Hydroxylases involved in vitamin D metabolism are differentially expressed in murine embryonic kidney: application of whole mount in situ hybridization.

K. Ozono, T. Michigami, M. Nakayama, 2001, Endocrinology.

Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha.

K. Ozono, M. Murakami, T. Michigami, 2007, Biochemical and biophysical research communications.

Analysis of the Molecular Mechanism for the Antagonistic Action of a Novel 1α,25-Dihydroxyvitamin D3 Analogue toward Vitamin D Receptor Function*

K. Ozono, T. Michigami, S. Nakajima, 1999, The Journal of Biological Chemistry.

Extracellular Phosphate, Inflammation and Cytotoxicity.

M. Razzaque, T. Michigami, M. Yamazaki, 2022, Advances in experimental medicine and biology.

Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.

K. Ozono, T. Michigami, M. Ihara-Watanabe, 2001, Cancer research.